VMQ StocksFor the value investor looking to harness academic research in
an actively managed portfolio
Bits and BipsNewsletter delivering insights on linking traditional finance, macro trends and cryptocurrency opportunities to help investors build stronger, more diversified portfolios.
All premium products come with free basic membership.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Learn more about Shuttle Pharmaceuticals Holdings Inc's (SHPH) stock grades for Growth and determine whether this Pharmaceuticals stock meets your investment needs.
Jenna Brashear
Financial Summary
Share Statistics
SHPH
Industry Median
Percentile (All Stocks)
Market Cap (Mil)
$2.2
$252.6
1%
Shares Out (Mil)
0.5
52.3
3%
Institutional Ownership
88.7%
92.1%
57%
Float (Mil)
0.6
40.2
1%
Beta
1.22
0.95
71%
Avg Daily Volume (000s)
862
455
68%
Price Change (52-week)
(89.8%)
52.9%
4%
Growth
SHPH
Industry Median
Percentile (All Stocks)
Sales (5yr)
na
13.6%
na
Net Income (5yr)
(71.0%)
(9.9%)
4%
EPS (5yr)
na
16.0%
na
Dividends (5yr)
na
0.0%
na
Cash Flow (5yr)
na
(15.6%)
na
Estimates
Qtrly
Current Fiscal Year
Next Fiscal Year
# of Estimates
na
na
na
Current EPS
na
na
na
Month Ago EPS
na
na
na
# Rev Up
na
na
na
# Rev Down
na
na
na
Three Months Ago EPS
na
na
na
Year/Year Chg
na
na
na
Financials
SHPH
Industry Median
Percentile (All Stocks)
Sales (TTM) (Mil)
na
$38
na
Net Income (TTM) (Mil)
($11)
($43)
29%
EPS (TTM)
($38.711)
($1.600)
2%
Operating Cash Flow (TTM) (Mil)
($9)
($31)
20%
Net Cash Flow (TTM) (Mil)
na
$5
na
Long-Term Debt (Q1) (Mil)
$0
$5
10%
Enterprise Value (Q1) (Mil)
$1
$180
4%
Valuation
SHPH
Industry Median
Percentile (All Stocks)
P/B
0.63
2.56
12%
P/E
na
19.0
na
Dividend Yield
na
0.0%
na
PEG (5yr hist)
na
0.9
na
Ratios
SHPH
Industry Median
Percentile (All Stocks)
Gross Margin
na
63.8%
na
Net Margin
na
(67.3%)
na
ROA
(126.4%)
(49.8%)
4%
ROE
(326.4%)
(55.5%)
2%
Liabilities to Assets
71.7%
30.3%
67%
F-Score
3
3
na
Shuttle Pharmaceuticals Holdings, Inc. did not pass any screens on 7/31/2026.
Looking for access to this powerful feature? Take the first step in becoming an A+ Investor today.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors